PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Swiss Specialist Addresses Cell Society Members at Inaugural Scientific Summit in La Jolla

Dr. Kai-Uwe Schlaudraff, a plastic surgery specialist from Geneva, Switzerland, recently addressed the topic of therapies based on stem cell enriched fat transfer before members of the Cell Society's 1st Annual Clinical Meeting.

2011-04-07
GENEVA, SWITZERLAND, April 07, 2011 (Press-News.org) Dr. Kai-Uwe Schlaudraff (www.concept-clinic.ch), a plastic surgeon who performs a wide range of plastic surgery procedures in Geneva, delivered a presentation on the topic of stem cell enriched fat transfer at the Cell Society's 1st Annual Clinical Meeting at the Estancia La Jolla Hotel & Spa in La Jolla, California. The meeting was held February 18 and 19, 2011.

"The desire to know more about the use of stem and regenerative cells in cosmetic medicine is widespread," says Dr. Schlaudraff. "Practitioners, patients and policy-makers worldwide must take an educated approach to weighing the benefits and risks of utilizing these therapies."

The Cell Society's meeting was designed to do exactly that by bringing global thought leaders like Dr. Schlaudraff together to educate physicians about the numerous "clinical applications of adult stem and regenerative cell therapies" which are being put into practice worldwide.

"More and more, I am integrating stem cell enriched fat transfer techniques when performing liposuction and bodysculpting procedures in Geneva, Switzerland," notes Dr. Schlaudraff. "Using cell enriched fat grafting, volume can be added to areas of the body and face including buttocks, breasts, cheeks, lips and hands. I also use this therapy to improve the appearance of scars and other skin imperfections."

Dr. Schlaudraff's presentation, "Autologous Fat Grafting to the Breast - Use, Safety, Risks," was well received as a key entry in the Breast & Soft Tissue Application portion of the Cell Society meeting. The event was jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Medical Education Advocates.

"While any discussion of fat grafting can get quite technical, I've put the information I think would benefit patients the most on my website," adds Dr. Schlaudraff. "Resources there include a diagram of the surgical procedure, a list of areas that can benefit from treatment, and a detailed description of how cell enriched fat grafting improves upon the traditional technique."

Dr. Schlaudraff has been a major contributor in many clinical research projects with a focus on growth factors and fatty tissue, as well as adipose-derived stem and regenerative cells and fat grafting to the breast. He is a key opinion leader whose work has been published in well-respected clinical journals worldwide.

At the Concept Clinic, Dr. Kai-Uwe Schlaudraff (www.concept-clinic.ch) performs reconstructive and cosmetic plastic surgery in Geneva, Switzerland. He is known for procedures including breast augmentation, cell-enriched fat grafting, liposuction, and facelifts. Dr. Schlaudraff graduated from medical school at the University of Freiburg, Germany where he received his MD degree in fundamental and clinical research on angiogenesis and growth factors in cardiovascular surgery. After having trained in London and Paris, he completed his general surgery residency in Basel, Switzerland and received his training in plastic surgery as a resident and registrar at the University Hospital of Geneva, Switzerland.


ELSE PRESS RELEASES FROM THIS DATE:

New fusion gene plays role in some stomach cancers

2011-04-07
DURHAM, N.C. – A newly discovered hybrid gene appears to play a direct role in some stomach cancers, according to an international team of scientists led by researchers at Duke-NUS Graduate Medical School Singapore. The hybrid gene is a fusion of two separate genes, and is one of the first described in gastric cancer, which is the most lethal malignancy worldwide after lung cancer. The disease kills an estimated 740,000 people a year, including nearly 11,000 annually in the United States. The gene discovery may one day give doctors a more effective way to use current ...

Ophthalmology Practice in San Luis Obispo Sponsors SLO Symphony's 50th Anniversary

Ophthalmology Practice in San Luis Obispo Sponsors SLO Symphonys 50th Anniversary
2011-04-07
Pacific Eye (www.paceyemd.com), the premier ophthalmology practice that provides optometry services in San Luis Obispo and Santa Barbara counties, continues to support the communities it serves with its sponsorship of the SLO Symphony's 50th anniversary season. Pacific Eye is known for providing comprehensive vision care services, including routine eye care, cataract surgery, and refractive surgical procedures including IntraLase LASIK in San Luis Obispo. In addition to their professional services, the practice is devoted to supporting their community. For example, ...

New Advance Website Features Improved Design to Facilitate Easy Product Selection by Product Type or Vertical Market

New Advance Website Features Improved Design to Facilitate Easy Product Selection by Product Type or Vertical Market
2011-04-07
Advance announces its new website with an enhanced structural design and efficient navigation tools for improved product selection and comprehensive service information. Providing a clean layout, the new website allows users to quickly access product information--including service manuals and parts list--by browsing various product categories or searching within multiple vertical markets. Featuring a simple navigation bar, users can easily locate Advance products or learn about Advance's comprehensive cleaning solutions, including its innovative EcoFlex System cleaning ...

MediaBoss Television Expands to Six Thousand Square Foot Studio

MediaBoss Television Expands to Six Thousand Square Foot Studio
2011-04-07
MediaBoss Television, a broadcast media, full creative, audio and video production company, announced today their expansion to a six thousand square foot facility in Framingham, Mass. MediaBoss Television provides the best digital content, creative services video and audio production to a variety of companies in the area like IBM, VGo Communications and Ipswitch, Inc. MediaBoss Television also produces local entertainment show, "Track Gals," which airs both on Boston CBS affiliate Channel 4 as well as WSBK's TV38. "The expansion of MediaBoss is a large step in achieving ...

New study solidifies role of DISC1 in risk for schizophrenia and other mental illness

2011-04-07
Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders. The findings, published online in the journal Nature, expand the possibility of creating biomarkers that can better diagnose those with mental illnesses and track their treatment. Building on previous studies at Hopkins, the new research further offers clues to why the Disrupted In Schizophrenia gene (DISC1) and its protein product plays so many distinct ...

Brain development switch could affect schizophrenia, other conditions

2011-04-07
DURHAM, N.C. – An international team of scientists lead by researchers from Duke University and Johns Hopkins University have discovered a key "switch" in the brain that allows neurons to stop dividing so that these cells can migrate toward their final destinations in the brain. The finding may be relevant to making early identification of people who go on to develop schizophrenia and other brain disorders. "This work sheds light on what has been a big black box in neuroscience," said Nicholas Katsanis, Ph.D., co-senior author of the work and Jean and George Brumley ...

Human taste cells regenerate in a dish

2011-04-07
PHILADELPHIA (April 6, 2011) – Following years of futile attempts, new research from the Monell Center demonstrates that living human taste cells can be maintained in culture for at least seven months. The findings provide scientists with a valuable tool to learn about the human sense of taste and how it functions in health and disease. This advance ultimately will assist efforts to prevent and treat taste loss or impairment due to infection, radiation, chemotherapy and chemical exposures. "People who undergo chemotherapy or radiation therapy for oral cancer often ...

Body mass index in adolescence associated with early occurrence of diabetes and heart disease

2011-04-07
Boston, MA - A new 17 year follow-up study of 37,000 Israeli teenagers found that diabetes risk is mainly associated with increased body mass index (BMI) close to the time of diagnosis at early adulthood, while coronary heart disease risk is associated with elevated BMI both at adolescence and adulthood. The findings are published in the April 7 issue of the New England Journal of Medicine. Lead study author, Amir Tirosh, MD PhD, of the Endocrine Division at Brigham and Women's Hospital said, "The study suggests that the obesity problem in children and teens is likely ...

Progesterone reduces rate of early preterm birth in at-risk women

2011-04-07
A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women. The women in the study had a short cervix, which is known to increase the risk for preterm birth. The cervix is the part of the uterus that opens and shortens during labor. The study also found that infants born to women who had received progesterone were less likely to develop respiratory distress syndrome, a breathing complication occurring in preterm ...

Some diabetes drugs are better than others, according to new study

2011-04-07
New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin. Insulin secretagogues (ISs), such as glimepiride, glibenclamide (known as glyburide in the USA and Canada), gliclazide and tolbutamide, have been used to treat type 2 diabetes since the 1950-1970s, Nevertheless, the long-term risk associated with these drugs has largely been unknown. Metformin is the first drug of choice in type 2 diabetes, ...

LAST 30 PRESS RELEASES:

Cleveland Clinic research finds injectable medications for obesity produce smaller weight loss in a real-world setting, compared to randomized clinical trials

Visionary psychedelic researcher reshapes treatment landscape for psychiatric disorders

Stanford researcher decodes sugar molecules' role in brain aging protection

Italian neuroscientist links childhood trauma to lifelong brain consequences

Personality disorder pioneer reveals half-century journey transforming psychiatric classification

Why regulating stem cell–based embryo model research is important (yet controversial)

An Alaskan volcano could help scientists understand why ‘stealthy’ volcanoes erupt without warning

Drive an electric motor without metal! KIST develops CNT-based ultra-lightweight coil technology

Cracking the spatial code: A new chapter in bone and muscle research

New oil and gas fields incompatible with Paris climate goals

Smartphone tests could accelerate drug development for Huntington’s disease

Significant gaps in testing for genetic cancer risk, study finds

Payment source shift for surgical care among veterans enrolled in Medicare Advantage plans

Study reveals how fatal school shootings disrupt local economies

American Psychological Association 2025 Convention, Aug. 7-9, Denver

Appendix cancer incidence has quadrupled in older millennials

Even bumble bee queens need personal days, too

Carbon capture method mines cement ingredients from the air

Fostering Integration: SELINA’s 5th project Workshop on the Azores unites partners to strengthen collaboration

Reelin marks cocaine-activated brain neurons and regulates cocaine reward

Creatine is safe, effective and important for everyone, longtime researcher says

Robots made of linked particle chains

Research alert: laying the groundwork for potential age-related macular degeneration therapies

It’s not the game, it’s the group: Sports fans connect the most over rituals

AI identifies key gene sets that cause complex diseases

Virginia Tech study sheds light on solar farm impacts to property values

Study defines key driver of aggressive ovarian cancer

Rings of time: unearthing climate secrets from ancient trees

Medical AI systems failing to disclose inaccurate race, ethnicity information

Light and AI drive precise motion in soft robotic arm developed at Rice

[Press-News.org] Swiss Specialist Addresses Cell Society Members at Inaugural Scientific Summit in La Jolla
Dr. Kai-Uwe Schlaudraff, a plastic surgery specialist from Geneva, Switzerland, recently addressed the topic of therapies based on stem cell enriched fat transfer before members of the Cell Society's 1st Annual Clinical Meeting.